Flavonoids are a class of over 6,500 plant metabolites that have been associated with reduced mortality from cardiovascular disease. A cross-sectional analysis of dietary flavonoids and serum cholesterol in 507 Blacks with and without type 2 diabetes (258 Haitian-Americans and 249 African-Americans) showed differences by ethnicity and diabetes status. Haitian-Americans consumed more of most flavonoids as compared to African-Americans. Individuals with type 2 diabetes consumed less of most flavonoids as compared to those without diabetes. Flavonoids were differentially associated with low-density lipoprotein cholesterol (LDL) and high-density lipoprotein cholesterol (HDL) by diabetes status. Flavanones were associated with lower LDL for participants without diabetes and higher LDL for those with diabetes, independent of ethnicity and adjusted for age, gender, cholesterol medications, daily energy, dietary fat, body mass index (BMI), and smoking. Flavan-3-ols were positively related to LDL while polyflavonoids (theaflavin and polymers, proanthocyanidins) were inversely related to LDL for the group without diabetes only. Higher anthocyanidins and flavan-3-ols and lower polyflavonoids were associated with higher HDL (same adjustments) for those without diabetes, whereas no flavonoids were associated with HDL for individuals with type 2 diabetes.
INTRODUCTION
Flavonoids (bioflavonoids) are a diverse group of more than 6500 polyphenols (phenyl benzopyrans) 1 which function as phytochemicals. Flavonoids are secondary plant metabolites found primarily in fruits, vegetables and seeds and are generally classified into categories based on their chemical structure. There is a lack of consensus for some of the flavonoid-subgroups. This may be due to the fact that subclasses of flavonoids are differentiated on the basis of the number and nature of substituent groups attached to the rings. 2 Isoflavones have been considered a separate category and the distinction of polyflavonoid is not always made. 3 Classification by the degree of unsaturation and degree of oxidation of the three carbon segment results in the following major classes: flavones, isoflavones, flavonols, anthocyanidins (or anthocyanins), flavanones, flavan-3-ols, chalcones and aurones. 1 It has been demonstrated throughout the literature that diets high in plant-based foods are protective against the development of cardiovascular disease, diabetes and cancer and that flavonoids have been thought to contribute to the protective role. 4, 5 Flavonoids incorporated in the diet exhibit several biological effects, such as anti-oxidant and antiinflammatory properties. 6 Flavan-3-ols and proanthocyanidins have been associated with reduction of risk for cardiovascular disease by increasing the release of endothelial nitric oxide and inducing vasodilatation. 7, 8 The antioxidant property of dietary flavonoids may be of particular benefit to persons with diabetes since their hyperglycemic condition depletes natural anti-oxidants and may result in oxidative stress.
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Dietary flavonoids (flavonols and flavones) were inversely related to mortality from coronary heart disease for a fiveyear cohort of N=805 men aged 65-84 years. 10 Dietary anthocyanidins and flavanones decreased coronary heart disease deaths, but not stroke, in post-menopausal women (N=34,492). This study aimed to compare flavonoid type with serum LDL and HDL in two ethnicities of Blacks: Haitian-and African-American with and without type 2 diabetes. We expect higher intake of certain flavonoids will collectively be associated with lower LDL and higher HDL independent of ethnicity and diabetes status. Backward method (probability of F-toremove ≥ 0.100) for flavonoids (anthocyanidins, poly flavonoids, flavan-3-ols, flavones, flavanone, flavonoid-noproanthocyanidins, flavonols, all natural log transformed) and Block 2: Enter method (forced entry) for ethnicity, gender, current smoker, total daily energy (Kcal/d), BMI, dietary fat, cholesterol medications, and age was conducted to determine associations with the dependent variables HDL and LDL (both natural log transformed). The results were considered statistically significant if the two-tailed p-value was < 0.05. Statistical analysis was performed using SPSS (version 18).
MATERIALS AND METHODS

SUBJECTS ASSESSMENT OF DIETARY INTAKE AND TOTAL USDA FLAVONOIDS
RESULTS
Several differences in flavonoid intake were observed comparing with and without diabetes. Table 1 . There were differences in several flavonoids by diabetes status for HA, whereas there were no differences for AA. One-way Analysis of Covariance (ANCOVA) comparing HA and AA, stratified by diabetes status, showed that HA without diabetes consumed more flavonols (p = 0.015) and flavones (p = 0.028) than AA without diabetes (data not shown). Ŧ Total flavonoids without proanthocyanidins.
The final models for the association of flavonoids with HDL and LDL are presented in Tables 2 and 3 , respectively. The results are stratified by diabetes status and all models were adjusted for ethnicity, age, gender, current smoker (yes/no), total daily energy intake, and cholesterol medication (yes/no). Lower LDL was associated with higher intake of flavanones for participants with diabetes; whereas, higher flavan-3-ols, and flavanones and lower polyflavonoids were related to lower LDL in the group without diabetes. There was a positive association for HDL with anthocyanidins and flavan-3-ols and an inverse relationship with polyflavonoids for the group without diabetes. There was no relationship between HDL and flavonoids for the group with diabetes. however, they did not test any other flavonoids. Naringin (a flavanone found primarily in grapefruit and other citrus) administered in supplement form for an 8-week trial was found to lower LDL concentrations by 17% in the hypercholestererolemic group (n=30) as compared with healthy controls (n=30). 22 Flavanones (hesperidin (found mostly in oranges) and naringin did not improve cholesterol (total, LDL or HDL) in a 4-week intervention of 194 hypercholesterolemic men and women; 12 however, the study was of a short duration. Phenols extracted from the fruit and measured as milligrams of gallic acid per kilogram of fresh weight were found to increase HDL and LDL for nonsmokers and decrease LDL for smokers in a 26-week intervention of fruit (one apple, one pear and 200 ml of orange juice each day) in 14 smoking-and 18 non-smokingnormo-lipid adults (aged 23-60) from Northern Mexico. 23 Although LDL was raised for non-smokers, their baseline and final level were within the normal range.
On the other hand, some interventions report no improvement of cholesterol with the administration of select flavonoids. A systematic review indicates there has been mixed reporting of epidemiologic evidence for cardiovascular effects of diets rich in flavonoids. 24 No heterogeneity of flavonoid-type and HDL was found by meta-analysis of 102 trials and minimal effects were found with green tea (catechins, flavan-3-ols) and for soy protein isolate (isoflavones) for the reduction of LDL. 24 The evidence for other flavonoids classifications was that they had no effect on LDL. 24 Lack of agreement with food flavonoids and cholesterol may be due to varying composition of flavonoid type and amount. For some studies, the bioavailability of the flavonoids was not established since their assessment was based on a FFQ and not assessed in blood. Environmental conditions of the food sources as well as human genetic differences could account for differences in availability, absorption and metabolic use of flavonoids. The data presented here should be considered preliminary since the sample size was modest and the study was collected at a single time point. These results suggest randomized control studies aimed at improving cholesterol with foods or supplements containing flavonoids are warranted. In consideration of safety, flavonoids in supplemental form (beyond the normal dietary intake) would require evaluating the kinetics and toxicity with respect to botanical-drug interactions, dosage level and the matrix (additional ingredients in the supplement).
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The current study had several limitations. First, it was a single time point, and causal relationship between flavonoids and serum cholesterol could not be established. Second, flavonoid types and amounts were based on analysis of a FFQ which was obtained by self-report. Self-reported food data may be under or over-reported. In addition, the intrinsic (bioavailability) and extrinsic (environmental) factors of the flavonoids varied and were not measured.
CONCLUSION
This data showed differences in consumption of several flavonoid types between ethnicity and disease state (with or without type 2 diabetes). Dietary flavonoids were associated differently with HDL and LDL by diabetes status but not ethnicity. To its merit, the present study adds much needed epidemiological data for two Black ethnicities. Haitian-and African-Americans are likely to have different dietary preferences and nutrigenomics. Another novel aspect of this study was the comparison of Blacks with and without type 2 diabetes with respect to flavonoid intake and the association with HDL and LDL.
